左旋咪唑
肾病综合征
医学
肾小球肾炎
免疫学
儿科
重症监护医学
内科学
肾
作者
Eugene Yu-hin Chan,Olivia Boyer
标识
DOI:10.1016/j.kint.2024.01.030
摘要
In the current issue of Kidney International, Sinha et al. present data from an open-label, noninferior, randomized controlled trial comparing 12-months of alternate-day prednisolone, given daily during infection, versus levamisole, in children with frequently relapsing or steroid-dependent nephrotic syndrome. This study suggests that both of these strategies are efficacious and safe. Results of this study should redefine the role of levamisole in future guidelines, and a call for global availability of levamisole should be advocated.
科研通智能强力驱动
Strongly Powered by AbleSci AI